Revolutionizing orthopedic healthcare: a systematic review unveiling recombinant antimicrobial peptides
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The increasing demand for orthopedic surgeries, including joint replacements, is driven by an aging population and improved diagnosis of joint conditions. Orthopedic surgeries carry a risk of infection, especially in patients with comorbidities. The rise of antibiotic resistance exacerbates this issue, necessitating alternatives like in vitro bioengineered antimicrobial peptides (AMPs), offering broad-spectrum activity and multiple action mechanisms. This review aimed to assess the prevalence of antimicrobial potential and the yield after purification among recombinant AMP families. The antimicrobial potential was evaluated using the Minimum Inhibitory Concentration (MIC) values against the most common bacteria involved in clinical infections. This systematic review adhered to PRISMA guidelines, focusing on in vitro studies of recombinant AMPs. The search strategy was run on PubMed, Scopus and Embase up to 30 th March 2023. The Population, Exposure and Outcome model was used to extract the data from studies and ToxRTool for the risk of bias analysis. This review included studies providing peptide production yield data and MIC values against pathogenic bacteria. Non-English texts, reviews, conference abstracts, books, studies focusing solely on chemical synthesis, those reporting incomplete data sets, using non-standard MIC assessment methods, or presenting MIC values as ranges rather than precise concentrations, were excluded. From 370 publications, 34 studies on AMPs were analyzed. These covered 46 AMPs across 18 families, with Defensins and Hepcidins being most common. Yields varied from 0.5 to 2,700 mg/L. AMPs were tested against 23 bacterial genera, with MIC values ranging from 0.125 to >1,152 μg/mL. Arenicins showed the highest antimicrobial activity, particularly against common orthopedic infection pathogens. However, AMP production yields varied and some AMPs demonstrated limited effectiveness against certain bacterial strains. This systematic review emphasizes the critical role of bioengineered AMPs to cope infections and antibiotic resistance. It meticulously evaluates recombinant AMPs, focusing on their antimicrobial efficacy and production yields. The review highlights that, despite the variability in AMP yields and effectiveness, Arenicins and Defensins are promising candidates for future research and clinical applications in treating antibiotic-resistant orthopedic infections. This study contributes significantly to the understanding of AMPs in healthcare, underscoring their potential in addressing the growing challenge of antibiotic resistance. Systematic review registration:https://osf.io/2uq4c/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antimicrobial peptides (AMPs) have been incorporated into biomaterials for orthopedic implants, showing reduced bacterial colonization and lower post-surgical infection rates [100].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [100]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 2×
“…activity against bacteria (Gram-positive and Gram-negative), viruses (enveloped and non-enveloped), yeasts, fungi, molds, and parasites (Zasloff, 2002; Radek and Gallo, 2007; Marxer et al., 2016); (ii) multiple mechanisms of action on different biological targets to traditional…”
BackgroundSolid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647 · cited 1×
“In chemical production, solid-phase-peptide synthesis is the most common method used, also at industrial scale (Merrifield, 1963).”
MethodAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829 · cited 1×
“…nucleic acids, the binding with the precursor lipid II crucial for the peptidoglycan synthesis, the interaction with different chaperone proteins to block the protein folding pathway, resulting in bacterial death (Otvos et al., 2000; Brogden, 2005; Essig et al., 2014; Mardirossian et al., 2018).”
BackgroundJenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518 · cited 1×
“These peptides usually are less than 100 amino acids long, especially consisting of positively charged (i.e., lysine, arginine, and histidine) and hydrophobic residues, these latter accounting for more than 50% (Jenssen et al., 2006).”
BackgroundAntimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351 · cited 1×
“…the cell surface resulting in the disruption of membrane integrity: in detail, the first essential step of interaction is represented by the electrostatic binding of the positively charged residues of AMPs to the anionic lipids of bacterial cell membrane (Bahar and Ren, 2013; Kumar et al., 2018).”
BackgroundKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190 · cited 1×
“…of action on different biological targets to traditional antibiotics and distinct pathways, thus decreasing the propensity for resistance to occur (Hancock and Chapple, 1999; Zasloff, 2002); (iii) regulation of key immunomodulatory mechanisms in the innate immune system (Al-Rayahi and Sanyi,…”
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060
Shichman, I., Roof, M., Askew, N., Nherera, L., Rozell, J. C., Seyler, T. M., & Schwarzkopf, R. (2023) · JBJS Open Access · doi:10.2106/jbjs.oa.22.00112 · Cited by 677 · cited 1×
“This trajectory is expected to persist, given the aging demographic and the increasing need for joint replacement procedures (Shichman et al., 2023).”
Background
Research works printed but not linked: 1
- EUCAST (2024). The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Disk diffusion method for antimicrobial susceptibility testing, version 12.0. 2024. https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology
Cited by
Antimicrobial Peptides: Mechanisms, Applications, and Therapeutic Potential
Alzain, M., Daghistani, H., Shamrani, T., Almoghrabi, Y. M., Daghistani, Y., Alharbi, O., Sait, A. M., Mufrrih, M., Alhazmi, W. A., Alqarni, M. A., et al. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s514825 · Cited by 73
Goulian, A. J., Goldstein, B., & Saad, M. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062061 · Cited by 25
“Antimicrobial peptides (AMPs) have been incorporated into biomaterials for orthopedic implants, showing reduced bacterial colonization and lower post-surgical infection rates [100].”
Campoccia, D., Bottau, G., Donno, A. D., Bua, G., Ravaioli, S., Capponi, E., Sotgiu, G., Bellotti, C., Costantini, S., & Arciola, C. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413241 · Cited by 16
Pennone, V., Angelini, E., Šarlah, D., & Lovati, A. B. (2024) · Antibiotics · doi:10.3390/antibiotics13080764 · Cited by 16
“AMPs can be either synthetically produced or derived through recombinant techniques [7], providing versatile platforms for designing targeted anti-infective therapies.”
BackgroundSelf-citationRoy, R. K., Biswas, R., Roy, A., Chandra, R., Shaw, R., Shaw, A. K., & Bandopadhyay, R. (2025) · The Microbe · doi:10.1016/j.microb.2025.100477 · Cited by 9
Sun, M., Gao, X., Ye, B., Zhao, Y., Ledesma‐Amaro, R., Gao, J., & Wang, P. (2026) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2026.01.007 · Cited by 5
“Nonetheless, expressing certain proteins, especially those with high hydrophobicity, strong aggregation tendencies, or intrinsic toxicity, remains challenging [91,92].”
Mimi, N. S., Noman, A. A., Parvez, M. S., Nath, B., Roshnee, T. A., Talukder, M. A. A., Shaku, I. A., Singh, S., Rajput, D. S., & Subramaniyan, V. (2026) · Eurasian Journal of Medicine and Oncology · doi:10.36922/ejmo026110120 · Cited by 2
Lv, K., Fang, Y., He, C., Xin, J., Xue, C., & Dong, N. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117849 · Cited by 1
Peptide Therapeutics in Orthopaedics: Current Evidence and Future Directions
Urish, K. L., Osifo, S. E., & Steckbeck, J. D. (2026) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.26.00785
Metadata
- Authors
- Pennone, V., Rosini, E., Mascheroni, E., Gianola, S., Castellini, G., Bargeri, S., & Lovati, A. B.
- Affiliations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- University of Insubria (IT)
- Corresponding author
- Pennone, Vincenzo
- ORCID
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-04-29
- Volume
- 15
- Pages
- 1370826-1370826
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC11097975
- OpenAlex
- W4396241622
- Cited by
- 8
- References
- 89
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministero della Salute
- Università degli Studi dell'Insubria
- Regione Lombardia
- Fondazione Regionale per la Ricerca Biomedica (3414083 AMPROject, 3414083)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- bone and joint infections, antibiotic resistance, minimum inhibitory concentration, defensins, hepcidin, pathogenic bacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.